IBDEI06K ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2471,0)
 ;;=I87.2^^19^203^96
 ;;^UTILITY(U,$J,358.3,2471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2471,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,2471,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,2471,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,2472,0)
 ;;=I82.0^^19^203^51
 ;;^UTILITY(U,$J,358.3,2472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2472,1,3,0)
 ;;=3^Budd-Chiari Syndrome
 ;;^UTILITY(U,$J,358.3,2472,1,4,0)
 ;;=4^I82.0
 ;;^UTILITY(U,$J,358.3,2472,2)
 ;;=^5007846
 ;;^UTILITY(U,$J,358.3,2473,0)
 ;;=I82.1^^19^203^92
 ;;^UTILITY(U,$J,358.3,2473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2473,1,3,0)
 ;;=3^Thrombophlebitis Migrans
 ;;^UTILITY(U,$J,358.3,2473,1,4,0)
 ;;=4^I82.1
 ;;^UTILITY(U,$J,358.3,2473,2)
 ;;=^5007847
 ;;^UTILITY(U,$J,358.3,2474,0)
 ;;=I82.3^^19^203^69
 ;;^UTILITY(U,$J,358.3,2474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2474,1,3,0)
 ;;=3^Embolism/Thrombosis of Renal Vein
 ;;^UTILITY(U,$J,358.3,2474,1,4,0)
 ;;=4^I82.3
 ;;^UTILITY(U,$J,358.3,2474,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,2475,0)
 ;;=I87.1^^19^203^95
 ;;^UTILITY(U,$J,358.3,2475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2475,1,3,0)
 ;;=3^Vein Compression
 ;;^UTILITY(U,$J,358.3,2475,1,4,0)
 ;;=4^I87.1
 ;;^UTILITY(U,$J,358.3,2475,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,2476,0)
 ;;=T82.818A^^19^203^65
 ;;^UTILITY(U,$J,358.3,2476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2476,1,3,0)
 ;;=3^Embolism of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,2476,1,4,0)
 ;;=4^T82.818A
 ;;^UTILITY(U,$J,358.3,2476,2)
 ;;=^5054917
 ;;^UTILITY(U,$J,358.3,2477,0)
 ;;=T82.828A^^19^203^74
 ;;^UTILITY(U,$J,358.3,2477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2477,1,3,0)
 ;;=3^Fibrosis of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,2477,1,4,0)
 ;;=4^T82.828A
 ;;^UTILITY(U,$J,358.3,2477,2)
 ;;=^5054923
 ;;^UTILITY(U,$J,358.3,2478,0)
 ;;=T82.868A^^19^203^93
 ;;^UTILITY(U,$J,358.3,2478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2478,1,3,0)
 ;;=3^Thrombosis of Vascular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,2478,1,4,0)
 ;;=4^T82.868A
 ;;^UTILITY(U,$J,358.3,2478,2)
 ;;=^5054947
 ;;^UTILITY(U,$J,358.3,2479,0)
 ;;=I08.0^^19^204^5
 ;;^UTILITY(U,$J,358.3,2479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2479,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral and Aortic Valves
 ;;^UTILITY(U,$J,358.3,2479,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,2479,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,2480,0)
 ;;=I05.0^^19^204^8
 ;;^UTILITY(U,$J,358.3,2480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2480,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,2480,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,2480,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,2481,0)
 ;;=I05.1^^19^204^7
 ;;^UTILITY(U,$J,358.3,2481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2481,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,2481,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,2481,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,2482,0)
 ;;=I05.2^^19^204^9
 ;;^UTILITY(U,$J,358.3,2482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2482,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,2482,1,4,0)
 ;;=4^I05.2
 ;;^UTILITY(U,$J,358.3,2482,2)
 ;;=^5007042
 ;;^UTILITY(U,$J,358.3,2483,0)
 ;;=I05.8^^19^204^10
 ;;^UTILITY(U,$J,358.3,2483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2483,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,2483,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,2483,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,2484,0)
 ;;=I06.0^^19^204^2
